Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Brains Bioceutical
Vancouver, British Columbia, Canada
- Ownership
- Private
- Employees
- ~50
- Development stage
- Other
01
Overview
Brains Bioceutical manufactures pharmaceutical-grade cannabinoid APIs, has delivered over 500 GMP batches, and participates in 30+ clinical trials, supplying validated APIs for epilepsy, pain, addiction, and animal health across the globe. Its solid THC innovation enables new clinical research and regulatory pathways[1][3][4].
- Therapeutic areas
- OtherNeurologyPsychiatry
- Modalities
- Small moleculePhytochemicalBiologic (Cannabinoid as biologically derived)
- Industry
- Contract Manufacturing Organization
02
Partnerships
Vitabiotics (UK number one vitamin company)[1]early-stage drug development partners (multinational pharma)[1]
Beyond the preview
Go deeper on Brains Bioceutical.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Brains Bioceutical.